Journal of Gynecology and Women’s Health

Research Article

Stimulating Hormone Level in Cases of Recurrent Early Pregnancy Loss

Hesham M Galal¹, Amal Z Azzam¹, M Elmahdy¹*, Amira Osama¹ and Eman T Elsayed²

¹Department of Obstetrics and Gynecology, Alexandria University, Egypt

²Department of Clinical and Chemical Pathology, Alexandria University, Egypt

Submission: March 06, 2017; Published: August 23, 2017

*Corresponding author: Mohamed Elmahdy, Department of Obstetrics and Gynecology, Alexandria University, 13 gylis street off koleyetelteb street mehatetelraml, Alexandria, Egypt, Tel: 00201002413531; Email: mahdy_moh@yahoo.com

How to cite this article: Hesham M G, Amal Z A, M Elmahdy, Amira O,et al. Evaluation of Thyroid Antibodies and Thyroid Stimulating Hormone Level in Cases of Recurrent Early Pregnancy Loss. J Gynecol Women's Health 2017; 6(3): 555690. DOI: 10.19080/JGWH.2017.06.555690.

Abstract

Background: Autoimmune Thyroid Disease (AITD) is one of the most frequent causes of hypothyroidism in females during the fertile age. The prevalence of hypothyroidism in women in the reproductive age is about 2-3 %.

Objectives: Evaluate maternal anti-thyroid AB concentrations and TSH level in cases of recurrent miscarriage.

Patients and methods: 400 female patients divided into two groups .Group A: 200including women with history of early recurrent pregnancy loss. Group B: 200 women with at least 2 living children and without previous recurrent early pregnancy loss. Antithyroglobulin antibodies and anti-thyroid peroxidase using chemiluminescence immunoassay (Normal level up to 115 IU/ml and up to 35 IU/ml) and TSH level using chemiluminescence immunoassay (Normal level 0,350- 2 IU/ml) were assessed.

Results: 10.0% and 9% of cases (n=200) and 3.0% and the same 3.0% of control group (n=200) were positive for anti TG antibodies and anti TPO antibodies. There was no statistically significant correlation between levels of anti TG antibodies and anti TPO antibodies and RPL (p= 0.052). 19% of cases group showed abnormally high TSH level. On the other hand, 14% of control group showed high level TSH. There was no significant relation between recurrent pregnancy loss and abnormal TSH level (P= 0.34).

Conclusion: Neither TSH nor anti thyroid antibodies (ATG OR anti TPO) showed significant difference in cases with recurrent miscarriage.

Keywords: Autoimmune thyroid disease; Anti-thyroglobulin; Thyroid stimulating hormone

Introduction

Miscarriage is the spontaneous loss of the conceptus before 20 weeks of gestation. Potential risk of possible miscarriage before pregnancy is diagnosed is about 30%. In clinically detected pregnancy, it is 10-15% before 8^th week and 3% between 8^th and 20^th weeks. Recurrent miscarriage is defined as occurrence of two or more consecutive spontaneous miscarriage. It occurs in 1-2% of couples in the reproductive age group [1-4].

Recurrent miscarriage can be attributed to chromosomal anomalies, anticardiolipin antibodies and endocrine disorders such as poorly controlled diabetes mellitus, hyperprolactinaemia, thyroid diseases; and pelvic anatomic abnormalities. Recurrent miscarriage can be classified as either primary or secondary Primary cases are women who have lost all their pregnancies, whereas secondary miscarriage cases have had at least one live born infant [5].

Autoimmune Thyroid Disease (AITD) is one of the common causes of hypothyroidism in women in the reproductive age. The prevalence of hypothyroidism in the general population of reproductive age is 2-3%. Overt hypothyroidism is commonly associated with infertility, as thyroid hormones have a direct effect on granulosa cells, theca cells and oocyte maturation [6-8].

Autoimmune thyroid disorders are characterized by the presence of thyroid auto-antibodies (Abs), particularly thyroid peroxidase (TPO) auto Abs and anti-thymoglobulin (Tg) auto Abs. TPO is an enzyme responsible for iodination of tyrosine residues and coupling of iodinated residues to form thyroid hormones [9]. The presence of thyroid autoantibodies is relatively common in women in reproductive age. In an “unselected” population of women, the prevalence ranges from 6% to 20%, being even higher in women with a history of recurrent pregnancy loss, (1733%) and in women with a history of subfertility (10-31%)in the developed world, thyroid autoimmunity is the main cause of hypothyroidism, which itself results in poor obstetric outcomes [10,11].

Euthyroid women with thyroid autoimmunity are twice as likely to experience spontaneous miscarriages. This may be attributed to a generalised activation of the immune system, an increased risk of progression to subclinical hypothyroidism, or it could be due to the transplacental transfer of thyroid receptor blocking antibodies [9,12-15].

Hence, there is a need to screen for subclinical hypothyroidism and thyroid autoimmunity in pregnancy, especially in women with a history of spontaneous miscarriages. However, the management of women with recurrent miscarriage who have thyroid autoimmunity remains controversial.

The aim of this study is to evaluate the relation of maternal serum TSH and the percentage of recurrent miscarriage in cases with positive serum anti thyroid antibodies.

Patients

The study was be conducted on 200 woman in the age group of 21-35 years recruited from the outpatient antenatal care clinic in El Shatby Maternity university Hospital. The study was conducted from September 2014 till October 2015. This study has been approved by national research ethics committee and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Patients were divided in two groups

a. Group A: 200 female patients with history of recurrent miscarriage.

b. Group B: 200 female patients with at least 2 living children and without history of miscarriage.

Inclusion criteria

a. Patients within the reproductive age (21- 35).

b. Women with recurrent first trimester pregnancy loss (two or more first trimester pregnancy loss) [1].

c. The control group: women with at least 2 living children and without history of miscarriage.

Exclusion criteria

a. Women with known autoimmune disorders including patients with systemic lupus, antiphospholipid syndrome and anticardiolipin Antibody sero positive patients.

b. Women with history of cervical incompetence or any other uterine pathology.

c. Women already on treatment for thyroid dysfunction.

d. Women with known chromosomal disorders.

e. Women with known medical disorders as hypertension and diabetes.

Methods

All the patients were subjected to:

1. Written informed consent

2. Detailed history taking: Personal history: age, smoking, alcohol and drug intake. Medical as hypertension and diabetes. Surgical as thyroid operation. Obstetric history: gravidity, parity and Past history of abortion including number of abortions and duration of pregnancy in each.

3. Complete general examination including:-

I. General look as pallor, jaundice and tremors.

II. Vital signs blood pressure pulse, temperature and respiratory rate

III. Head and neck examination to exclude thyroid swelling

IV. Chest and cardiac examination

V. Abdominal examination to exclude abdominal and pelvic tumor

4. Ultrasound scanning to exclude any pelvic pathology

5. Karyotyping to exclude chromosomal anaomalies.

6. Laboratory investigations including:

a. Routin investigations: complete blood picture, blood group, RH and fasting blood glucose level.

b. Special investigation

1. Antithyroglobulin antibodies (Antithyroglobulin auto antibodies) using chemiluminescence immunoassay (Normal level up to 115 IU/ml.)

2. Anti thyroid peroxidase antibodies using chemiluminescence immunoassay. (Normal level up to 35 IU/ml.)

3. TSH level using chemiluminescence immunoassay (Normal level 0,350-5,500Uu/ml).

Results

The study was conducted on 200 woman in the reproductive age and were divided into two groups; Group A: 200 female patients with history of recurrent miscarriage and Group B: 200 female patients with at least 2 living children and without history of miscarriage.

There was no statistically significant difference between the two groups regarding age. The mean was 27.56±5.24 in the first group and 26.97±4.23 in the second group (p=0.382).

There was no statistically significant difference between the two studied groups regarding TSH level (2.95 ± 3.19 and 2.50±3.17) in cases with RPL and control women (p=0.14) (Table 1).

X²: Chi square test

FE: Fisher Exact test

Z: Z for Mann Whitney test

In group A(cases. group) the level of Antithyroglobulin and anti TPOauto antibodies was normal in180and 182 patients and abnormal in 20 and 18 patients with a mean value of 65.81±139.0 and 29.2± 7.22 In group B (control. group) the level of auto antibodies was similar for both ATG and ATPO. It was normal in 194 patients and abnormal in 6 patients with a mean value of 42.70±140.93 and 31.77± 8.5. There is no statistically significant difference between the two groups regarding Antithyroglobulin auto antibodies andanti-thyroid peroxidase antibodies level (p=0.053) and (P= 0.062) (Table 2).

X²: Chi square test

Statistically significant at ≤0.05

Z: Z for Mann Whitney test.

When cases with more than three abortions compared with cases with three or less abortions, there was no statistical significant difference as regards serum level of TSH (2.88 ± 2.95 and 3.02 ± 3.44) in cases with more and less than three miscarriage(p=0.722) (Table 3). There were no statistical significant difference between both groups as regards serum antithyroglobulin AB (55.05 ± 121.39 and 76.56 ± 155.12) in cases with more and less than three miscarriage (p=0.357) (Table 4).

Discussion

Miscarriage is the spontaneous loss of the conceptus before 20 weeks of gestation. Recurrent miscarriage, defined as occurrence of two or more consecutive spontaneous miscarriage .It occurs in 1-2% of couples attempting to get pregnancy [14]. The aim of this study was to evaluate maternal anti-thyroid auto antibodies (ATG and ATPO) antibodies concentration and TSH level in cases of recurrent miscarriage as there is a debate between this correlation.

The study was conducted on 400 woman in the reproductive age and were divided into two groups; Group A: 200 female patients with history of recurrent miscarriage and Group B: 200 female patients with at least 2 living children and without history of miscarriage.

In the present study there was no significant difference between serum level of TSH in the two studied groups (2.95±3.19 and 2.50±3.17) in cases with RPL and control women (p=0.14) respectively. Serum anti thyroglobulin and anti TPO antibodies level showed a non-significant elevation in the group with recurrent pregnancy loss than in the control group (p=0.053) and (P= 0.062).

These results were in agreement with Pratt and his colleagues who failed to reach statistical significance (p=0.2) when they were tried to evaluate women with recurrent abortions for the presence of thyroid Abs compared with the controls [16]. Also, Esplin and his colleagues compared the rate of thyroid auto antibodies positivity in women with recurrent abortion with controls (p> 0.05 not statistically significant) [17]. In a study conducted in the same year, no difference was found in miscarriage rates between Ab-negative and Ab-positive women (p=0.29) [18]. In addition, it was concluded that the risk of pregnancy loss in women with unexplained recurrent miscarriages is not affected by their thyroid Abs status [19].

On the other hand, the present results were not concordant with some other studies in this field. Stagnaro-Green and his colleague Glinoer were reported a doubling of the miscarriage rate in women who were positive with Antithyroid Abs compared to those with negative Abs (p= 0.011, p<0.001), respectively [20, 21]. Also, Lejeune and his colleague were reported that the miscarriages are associated with Antithyroid Abs and took place early, within the first trimester of the pregnancy [22]. Several researchers reported that women with TPO Abs and/or TG Abs had a higher miscarriage rate than women who were negative for these antibodies (P< 0.05) respectively [23-26].

In the present study, thyroid dysfunction in the form of abnormal serum TSH level, serum antithyroglobulin antibodies and anti TPO antibodies showed no correlation with the number of pregnancy loss if we compared women with more and less than 3 miscarriages. This may be supported also by what was found that thyroglobulin message is not expressed in placenta, decidua, or ovary in any stages of pregnancy [27].

In the present study, we studied antithyroid antibodies (ATG and ATPO), while there is a lot of autoantibodies which were not tested in this study and may have a role in recurrent pregnancy loss. Antithyroid antibodies are known to occur in normal, healthy population, and these auto antibodies are five times more common in women than in men. Because of prominent prevalence of antithyroid antibodies in normal women, interpreting the significance of these antibodies in women with reproductive problems remains difficult [22]. It is also suggested that the presence of thyroid auto antibodies reflects a generalized activation of the immune system particularly of T cells, which are ultimately responsible for the loss of the pregnancy [23]. So, the effect of this Abs seen by some studies may reflect only some sort of association due to immunological over activity. The limitations of this study were that we didn't differentiate between clinical and subclinical hypothyroidism. We didn't do a correlation between T3 and T4 levels and RPL.